Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/15/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 111.1k | $52.40 | $5.8M | | 08/14/2023 |
08/15/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 72.9k | $52.40 | $3.8M | See footnote | 08/14/2023 |
08/14/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 2k | $54.80 | $109.6k | | 08/14/2023 |
08/14/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 75k | $52.00 | $3.9M | | 08/14/2023 |
08/14/2023 | Disc Medicine, Inc. | | Sale | Common Stock | 98k | $53.00 | $5.2M | | 08/14/2023 |
01/12/2023 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 77.1k | $30.29 | $2.3M | | 01/11/2023 |
01/12/2023 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 21.6k | $30.29 | $654k | See footnote | 01/11/2023 |
01/11/2023 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 21.7k | $29.96 | $649.6k | | 01/11/2023 |
01/11/2023 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 6.1k | $29.96 | $181.9k | See footnote | 01/11/2023 |
12/29/2022 | Disc Medicine, Inc. | | Other (acquisition) | Common Stock | 1.8M | $0.00 | $0 | | 12/29/2022 |
12/29/2022 | Disc Medicine, Inc. | | Other (acquisition) | Common Stock | 882.2k | $0.00 | $0 | See Footnote | 12/29/2022 |
12/15/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 2.6k | $30.00 | $76.8k | | 12/14/2022 |
12/15/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 717 | $30.00 | $21.5k | See footnote | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 112.8k | $30.28 | $3.4M | | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 101.2k | $31.44 | $3.2M | | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 54.7k | $32.33 | $1.8M | | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 14k | $33.34 | $466.7k | | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 13.3k | $34.02 | $453.7k | | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 31.6k | $30.28 | $956.4k | See footnote | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 28.3k | $31.44 | $890.7k | See footnote | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 15.3k | $32.33 | $495.4k | See footnote | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 3.9k | $33.34 | $130.7k | See footnote | 12/14/2022 |
12/14/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 3.7k | $34.02 | $127k | See footnote | 12/14/2022 |
11/03/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 75.3k | $30.00 | $2.3M | | 11/02/2022 |
11/03/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 21.1k | $30.00 | $632.6k | See footnote | 11/02/2022 |
11/02/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 96.6k | $30.02 | $2.9M | | 11/02/2022 |
11/02/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 27k | $30.02 | $811.7k | See footnote | 11/02/2022 |
11/01/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 56.5k | $30.57 | $1.7M | | 10/28/2022 |
11/01/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 15.8k | $30.57 | $483.1k | See Footnote | 10/28/2022 |
11/01/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 3.7k | $31.08 | $115.8k | | 10/28/2022 |
11/01/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 1k | $31.08 | $32.4k | See Footnote | 10/28/2022 |
10/31/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 94.2k | $30.23 | $2.8M | | 10/28/2022 |
10/31/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 26.4k | $30.23 | $797.6k | See Footnote | 10/28/2022 |
10/28/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 71.1k | $30.00 | $2.1M | | 10/28/2022 |
10/28/2022 | Kymera Therapeutics, Inc. | | Sale | Common Stock | 19.9k | $30.00 | $597.4k | See Footnote | 10/28/2022 |
|